Old Web
English
Sign In
Acemap
>
authorDetail
>
N Acheson
N Acheson
AstraZeneca
Angiogenesis
Biology
Vandetanib
Tyrosine-kinase inhibitor
Endothelial stem cell
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Vandetanib inhibits both pVEGFR2 and pEGFR at clinically achievable drug levels in preclinical models
2007
Molecular Cancer Therapeutics
Sandra R. Brave
Rajesh Odedra
Neil R. Smith
Neil H. James
Gayle Marshall
N Acheson
Zoe Howard
Dawn Baker
L. Jackson
M. Hickinson
Robert W. Wilkinson
Kirsty Ratcliffe
Mike Walker
Anna Wainwright
Simon T. Barry
Steve Wedge
Anderson J. Ryan
Show All
Source
Cite
Save
Citations (0)
In vitro effects of vandetanib on VEGFR2, EGFR and RET phosphorylation, endothelial cell tube formation, and tumor cell growth and survival
2007
Molecular Cancer Therapeutics
Sandra R. Brave
Gayle Marshall
Anna Wainwright
Neil H. James
N Acheson
Zoe Howard
Kirsty Ratcliffe
Georgina Speake
Simon T. Barry
D. Hickinson
Anderson J. Ryan
Show All
Source
Cite
Save
Citations (0)
1